Treatment persistence in patients with schizophrenia treated with lurasidone in Italian clinical practice
Abstract Background and rationale Treatment persistence combines clinician and patient judgment of efficacy, tolerability and safety into a comprehensive measure of effectiveness and is defined as the act of continuing a treatment over time. Studies have reported poor treatment persistence to antips...
Main Authors: | Andrea Fagiolini, Miriam Olivola, Lisa Lavatelli, Antonello Bellomo, Caterina Lobaccaro, Nathalie Falsetto, Marco Micillo, Alessandro Cuomo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Annals of General Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12991-022-00425-y |
Similar Items
-
Cost analysis of lurasidone for the treatment of schizophrenia in adolescents and adults within the United Kingdom
by: Amy Dymond, et al.
Published: (2022-08-01) -
Real-world treatment patterns and outcomes in patients initiating lurasidone for the treatment of schizophrenia in Europe
by: A. Jones, et al.
Published: (2022-06-01) -
The Role of Lurasidone in Managing Depressive Symptoms in People with Schizophrenia: A Review
by: Andrea Fiorillo, et al.
Published: (2024-02-01) -
Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: Pooled analysis of double-blind, placebo-controlled 6-week studies
by: F. Calisti, et al.
Published: (2021-04-01) -
Lurasidone in adolescents with schizophrenia: Sustained remission and recovery during 2 years of open-label treatment
by: M. Tocco, et al.
Published: (2021-04-01)